Please assess the completion status of the following clinical trial:

Trial Title: Visualisation of the Central Analgesic Effect of Paracetamol in Functional MRI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* - Healthy volunteers~* Aged at last 18 years and over 60 years~* Male~* Non-smoking subject~* Fasting coffe, tea, coca-cola or other stimulant products since the last evening~* Subject free of any treatment within 7 days prior to inclusion including no use of analgesics or anti-inflammatory treatments~Exclusion Criteria:~* Contraindications to the administration of paracetamol~* Contraindications to the completion of MRI~* Medical history and/or surgical judged by the investigator as being incompatible with the test~* Progressive disease at the inclusion

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- paracetamol (Type: EXPERIMENTAL): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).